Back to search

University of Leeds

Mri-only treatment planning for anal and rectal cancer radiotherapy (MANTA-RAY)

Abstract

dc:description.abstract

Introduction: A barrier to the widespread clinical implementation of magnetic resonance imaging (MRI)-only radiotherapy planning for pelvic sites is the limited assessment in the literature demonstrating technical achievability and benefit. The MRI-only treatment planning for anal and rectal cancer radiotherapy (MANTA-RAY) study aimed to validate synthetic-CT (computed tomography) model generation accuracy, show the viability of cone beam CT (CBCT) patient positioning using synthetic-CT and MRI as a reference image, assess the patient experience of radiotherapy MRI scans and quantify potential clinical benefits of MRI-only patient treatments for anal and rectal cancer sites. Methods: The MANTA-RAY study recruited 46 patients with anal and rectal cancers who received radiotherapy CT and MRI scans after informed consent. A deep learning synthetic-CT model was trained and validated in terms of dosimetric calculation accuracy. Differences in CBCT patient position registration accuracy were assessed when using synthetic-CT and MRI as the reference images. The patient experience of the MRI simulation was assessed. A planning study quantified the differences between MRI- and CT-only planned treatments. Results: The synthetic-CT model had excellent dosimetric accuracy (planning target volume (PTV) D95% dose difference to CT = 0.1%). MRI and synthetic-CT reference images had systematic differences to CT in all translational and rotational dimensions of <1 mm and <0.5 °. The radiotherapy MRI patient experience was found to be better or similar to the CT experience for the majority of respondents. MRI-only target volume delineations resulted in statistically significant GTV (gross tumour volume) and primary PTV volume reductions and treatment plan dose reductions to healthy organs compared with CT-only plans. Conclusions: These findings provide evidence that MRI-only treatment planning for anal and rectal cancers is technically achievable and accurate, can be clinically implemented without detrimentally affecting the patient pathway and could lead to improved patient outcomes if organ dose reductions translate into less treatment related toxicity.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Bird, David Mark
Advisors dc:contributor.advisor
  • Henry, Ann
  • Buckley, David
  • Sebag-Montefiore, David
  • Speight, Richard
  • Al-Qaisieh, Bashar
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.855591
Dc Identifier Grantnumber
ICA-CDRF-2017-03-005

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Bird, David Mark. Mri-only treatment planning for anal and rectal cancer radiotherapy (MANTA-RAY). doctoral thesis, University of Leeds, 2021.